S0511, Goserelin and Anastrozole in Treating Men With Recurrent or Metastatic Breast Cancer

Withdrawn before enrolling · Phase 2

Conditions studied: Breast Cancer

In brief

RATIONALE: Estrogen can cause the growth of breast cancer cells. Hormone therapy using goserelin and anastrozole may fight breast cancer by blocking the use of estrogen by the tumor cells. Giving goserelin together with anastrozole may be an effective treatment for male breast cancer. PURPOSE: This phase II trial is studying how well giving goserelin together with anastrozole works in treating men with recurrent or metastatic breast cancer.

Key facts

Study ID
NCT00217659
Run by
SWOG Cancer Research Network
People needed
0
Starts
2005-09-01
Expected to finish
2007-01-01
Last updated by the study team
2013-01-03

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.